Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.62 |
| ▸ | APEX1 | P27695 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.58 |
| ▸ | WDR5 | P61964 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL28606314 | 0.96 | L3MBTL1 (0.61) | L3MBTL1ALOX15SMN1; SMN2NR4A1APEX1 | |
| SCHEMBL421532 | 0.94 | L3MBTL1 (0.59) | L3MBTL1ALOX15SMN1; SMN2NR4A1APEX1 | |
| SCHEMBL27686481 | 0.91 | SMN1; SMN2 (0.59) | L3MBTL1ALOX15SMN1; SMN2NR4A1APEX1 | |
| SCHEMBL1550667 | 0.91 | FFAR1 (0.74) | L3MBTL1ALOX15SMN1; SMN2NR4A1APEX1 | |
| SCHEMBL11178905 | 0.89 | HPGD (0.63) | L3MBTL1ALOX15SMN1; SMN2NR4A1APEX1 | |
| SCHEMBL339492 | 0.89 | ALOX15 (0.81) | ALOX15SMN1; SMN2NR4A1APEX1ALDH1A1 | |
| SCHEMBL7530700 | 0.86 | ALOX15 (0.59) | L3MBTL1ALOX15SMN1; SMN2NR4A1APEX1 | |
| SCHEMBL11425674 | 0.84 | MAPT (0.61) | L3MBTL1ALDH1A1MAPTHPGDLMNA | |
| SCHEMBL10299391 | 0.84 | PTPN7 (0.71) | L3MBTL1ALOX15SMN1; SMN2NR4A1APEX1 | |
| SCHEMBL656832 | 0.83 | LMNA (0.67) | ALOX15SMN1; SMN2NR4A1APEX1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 686 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| WO-2023033605-A1 | METHOD FOR SCREENING SOLVENT FOR EXTRACTING POLYVINYL CHLORIDE, METHOD FOR RECYCLING WASTE, RECYCLED POLYVINYL CHLORIDE, AND COMPOSITION | 주식회사 엘지화학 | 2023-03-09 | — | — | WO | claimed |
| WO-2023033601-A1 | METHOD FOR SCREENING SOLVENT FOR POLYVINYL CHLORIDE EXTRACTION, RECYCLING METHOD FOR WASTE MATERIAL, AND RECYCLED POLYVINYL CHLORIDE AND COMPOSITION | 주식회사 엘지화학 | 2023-03-09 | — | — | WO | claimed |
| CN-115745457-A | High-adaptability concrete superplasticizer, preparation method and application thereof | 南京博特新材料有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115725035-A | Slump-retaining concrete superplasticizer, preparation method and application thereof | 博特新材料泰州有限公司 | 2023-03-03 | — | — | CN | claimed |
| US-20220401275-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2022-12-22 | — | — | US | claimed |
| EP-3509647-B1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2020-10-21 | — | — | EP | claimed |
| EP-3509647-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | The Procter and Gamble Company (US) | 2019-07-17 | — | — | EP | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| US-6410490-B1 | OIL ADDITIVE MIXTURE | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-06-25 | — | — | US | claimed |
| EP-1054052-A2 | Stabilized hydrotreated and hydrodewaxed lubricant compositions | Ciba SC Holding AG (CH) | 2000-11-22 | — | — | EP | claimed |
| EP-0431248-A1 | Process for preparation of alpha-aryloxy acetic acids and their salts | G.D. Searle & Co. (US) | 1991-06-12 | — | — | EP | claimed |
| US-4952724-A | Process for preparation of alpha-aryloxy acetic acids and their salts | G. D. SEARLE & CO. (US) | 1990-08-28 | — | — | US | claimed |
| US-4946761-A | POLYMER CONTAINING CARBOXYL END GROUPS | FUJI PHOTO FILM CO., LTD. (JP) | 1990-08-07 | — | — | US | claimed |
| EP-0159864-B1 | METHOD OF MODIFYING TASTE | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1989-07-19 | — | — | EP | claimed |
| EP-0159864-A2 | Method of modifying taste | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1985-10-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | L3MBTL1 1536/4885ALOX15 868/4885SMN1; SMN2 769/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | L3MBTL1 1554/4885ALOX15 797/4885SMN1; SMN2 692/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | L3MBTL1 4695/4885ALOX15 3060/4885SMN1; SMN2 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.